The synopsis for this grant opportunity is detailed below, following
this paragraph. This synopsis contains all of the updates to this
document that have been posted as of
09/25/2009
. If
updates have been made to the opportunity synopsis, update information
is provided below the synopsis.
If you would like to receive notifications of changes to the grant
opportunity click
send
me change notification emails
.
The only thing you need to provide for this service is your email
address. No other information is requested.
Any inconsistency between the original printed document and the disk
or electronic document shall be resolved by giving precedence to the
printed document.
Description of Modification
Revised to correct Link to Full Announcement: http://grants.nih.gov/grants/guide/rfa-files/RFA-HS-10-004.html
Document Type:
Modification to Previous
Grants Notice
Funding Opportunity Number:
RFA-HS-10-004
Opportunity Category:
Other
Posted Date:
Sep 25, 2009
Creation Date:
Oct 06, 2009
Original Closing Date for Applications:
Dec 16, 2009
Current Closing Date for Applications:
Dec 16, 2009
Archive Date:
Jan 16, 2010
Funding Instrument Type:
Grant
Category of Funding Activity:
Health
Recovery Act
Category Explanation:
Expected Number of Awards:
Estimated Total Program Funding:
$29,500,000
Award Ceiling:
$1,500,000
Award Floor:
CFDA Number(s):
93.715
--
Recovery Act-Comparative Effectiveness Research - AHRQ
Cost Sharing or Matching Requirement:
No
Eligible Applicants
State governments
County governments
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Native American tribal organizations (other than Federally recognized tribal governments)
Private institutions of higher education
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility:
Other Eligible Applicants include the following:
Faith-based or Community-based Organizations; Indian/Native American Tribal Governments (Other than Federally Recognized).
Agency Name
Agency for Health Care Research and Quality
Description
Purpose. This AHRQ Funding Opportunity Announcement (FOA), supported by funds provided to AHRQ under the American Recovery and Reinvestment Act of 2009 (Recovery Act or ARRA), Public Law 111-5, invites Research Demonstration and Dissemination grant (R18) applications from organizations to extend the reach and impact of Comparative Effectiveness Research (CER) Reviews and associated products, particularly Comparative Effectiveness Research Summary Guides (CERSGs) prepared by the John M. Eisenberg Center for Clinical Decisions and Communications Science part of the AHRQ Effective Health Care Program. (See http://effectivehealthcare.ahrq.gov/healthInfo.cfm?infotype=sg and http://effectivehealthcare.ahrq.gov/healthInfo.cfm?infotype=rr for information about CERSGs and CER Reviews respectively.) Summary guides are intended to help bridge the gap between research and practice by translating and disseminating findings on the comparative effectiveness of clinical interventions for three broad audiences patients/consumers, clinicians, and policymakers. Applicants are invited to propose innovative customizations or adaptations (as defined in this FOA under Part II Section I.1 Research Objectives subsection) to the content presentation and/or delivery mechanism(s) of one or more Comparative Effectiveness Research Review Products, such as Comparative Effectiveness Reviews, Comparative Effectiveness Review Executive Summaries, or Comparative Effectiveness Research Summary Guides (CERSGs) where additional adaptations or customizations are aimed at increasing their use, implementation, and impact among difficult-to-reach populations, including the elderly, those with limited English proficiency, limited education or insurance coverage, minority or immigrant status, health literacy problems, or other underserved populations who may have limited contact with the health care system or health information. Adaptations should aim to increase the impact and effective use of one or more CER Review Products by developing, implementing, and evaluating customizations that target important audiences, stakeholders, systems, or settings; these customizations may be in the adaptation of the original CER Review or Executive Summary contents to a specialized clinical audience of potential users (such as Formulary or Pharmaceutical and Therapeutics Committees, health care systems with electronic platforms such as electronic medical records (EMRs) that could support clinical decision support) or adaptation of CERSGs (supplemented as deemed necessary with pertinent information found solely in the CER Reviews) to underserved populations of patients/consumers whose interface with medical or Internet sources of information is limited and who may instead use health care information and advice provided through traditional means, such as neighborhood-, community-, or faith-based groups. For CER Review Products or CERSGs, adaptations may address the presentation of the content and/or the mechanisms by which the contents are delivered or used.
The following files represent the modifications to this synopsis
with the changes noted within the documents. The list of files is
arranged from newest to oldest with the newest file representing the
current synopsis. Changed sections from the previous document are shown
in a light grey background.
